Cargando…
RASAL2 down-regulation in ovarian cancer promotes epithelial-mesenchymal transition and metastasis
Ovarian cancer is the most lethal gynecologic malignancy, and transcoelomic metastasis is responsible for the greatest disease mortality. Although intensive efforts have been made, the mechanism behind this process remains unclear. RASAL2 is a GTPase activating proteins (GAPs) which was recently rep...
Autores principales: | Huang, Yuting, Zhao, Meng, Xu, Haixu, Wang, Ke, Fu, Zheng, Jiang, Yuan, Yao, Zhi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4196159/ https://www.ncbi.nlm.nih.gov/pubmed/25216515 |
Ejemplares similares
-
Overexpression of RASAL1 Indicates Poor Prognosis and Promotes Invasion of Ovarian Cancer
por: Chang, Rui-Xia, et al.
Publicado: (2019) -
RASAL2, a RAS GTPase-activating protein, inhibits stemness and epithelial–mesenchymal transition via MAPK/SOX2 pathway in bladder cancer
por: Hui, Ke, et al.
Publicado: (2017) -
MDM2 promotes epithelial–mesenchymal transition and metastasis of ovarian cancer SKOV3 cells
por: Chen, Ying, et al.
Publicado: (2017) -
Phosphorylated Rasal2 facilitates breast cancer progression
por: Wang, Xuan, et al.
Publicado: (2019) -
Ang-2 promotes lung cancer metastasis by increasing epithelial-mesenchymal transition
por: Dong, Zhizhen, et al.
Publicado: (2018)